Oncology Research and Treatment

Journal Abbreviation: Oncol Res Treat
ISSN: 2296-5270
eISSN: 2296-5262
Publisher: Karger Publishers

Publications (245)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Daratumomab for the treatment of relapsed multiple myeloma involving the central nervous system: a case report (2019) Brandt A, Seuß H, Mackensen A, Rösler W Conference contribution Monitoring of the immunometabolic profile of reconstituting leukocytes upon autologous peripheral blood stem cell transplantation (2019) Richter S, Jacobs B, Böttcher M, Stoll A, Böttcher-Loschinski R, Mackensen A, Mougiakakos D Conference contribution Successful targeting of BRAF V600E mutation with vemurafenib in a treatment-resistant extragonadal non-seminomatous germ cell tumor (2019) Meintker L, Haller F, Tögel L, Schmidt D, Waibel H, Mackensen A, Meidenbauer N Conference contribution The oncometabolite 5 '-methylthioadenosine (MTA) blocks NK cell functions early after activation (2019) Jacobs B, Schlögl S, Mougiakakos D, Mackensen A, Aigner M, Völkl S Conference contribution Regulation of immunological checkpoints in human mesenchymal stromal cells (2019) Strauch V, Saul D, Mackensen A, Jitschin R, Mougiakakos D Conference contribution AML-derived exosomes promote induction of myeloid-derived suppressor cells in an mTOR-signaling-dependent fashion (2019) Jitschin R, Tohumeken S, Saul D, Bruns H, Braun M, Mackensen A, Mougiakakos D Conference contribution Oxidative stress upon allogeneic hematopoietic stem cell transplantation and its impact on the reconstituting immune system (2019) Karl F, Böttcher-Loschinski R, Stoll A, Rösler W, Mackensen A, Mougiakakos D, Völkl S Conference contribution Human monocytes display different levels of CD137/4-1BB expression linked to certain immunometabolic features (2019) Stoll A, Bruns H, Saul D, Mackensen A, Mougiakakos D Conference contribution Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study (2019) Goebell P, Hermann E, Kube U, Doehn C, Marschner N, Dietel A, Blumenstengel K, et al. Journal article Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options (2019) Ahrens M, Scheich S, Hartmann A, Bergmann L Journal article, Review article